Share on StockTwits

C.R. Bard (NYSE:BCR) has received an average recommendation of “Hold” from the nineteen ratings firms that are currently covering the stock, Analyst Ratings Network reports. Two investment analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $144.25.

C.R. Bard (NYSE:BCR) opened at 148.63 on Tuesday. C.R. Bard has a 52 week low of $111.24 and a 52 week high of $154.16. The stock’s 50-day moving average is $146.1 and its 200-day moving average is $142.6. The company has a market cap of $11.093 billion and a P/E ratio of 15.07.

C.R. Bard (NYSE:BCR) last issued its quarterly earnings data on Thursday, July 24th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.05. The company had revenue of $827.10 million for the quarter, compared to the consensus estimate of $814.58 million. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, analysts predict that C.R. Bard will post $8.31 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Bank of America downgraded shares of C.R. Bard from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of C.R. Bard in a research note on Monday, July 28th. They now have a $156.00 price target on the stock. Finally, analysts at Raymond James reiterated an “outperform” rating on shares of C.R. Bard in a research note on Friday, July 25th. They now have a $170.00 price target on the stock, up previously from $155.00.

In other C.R. Bard news, VP Bronwen K. Kelly sold 10,055 shares of the stock in a transaction dated Monday, August 4th. The stock was sold at an average price of $150.25, for a total value of $1,510,763.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

C. R. Bard, Inc (NYSE:BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.